A NEW POSSIBILITY FOR WEIGHT MANAGEMENT ?

Scientists are increasingly examining retatrutide, a novel medication created by Eli Lilly, as a potential step in weight loss . Distinct from many previous approaches, retatrutide is a twin-action compound targeting both GLP-1 and GIP, hormones that influence satiety and glucose balance. Early